Gamunex-c 20 gram/200 ML vial 200ML
Ended Awarded
- Contract number
- SPE2DB25FJZ71
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,702
Award facts
- Contract value 100% obligated
- $17,702.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,702.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials on September 18, 2025, with an ultimate completion date of October 9, 2025. GAMUNEX-C is an intravenous immunoglobulin used to treat immunodeficiency disorders and autoimmune conditions. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through its comprehensive IDC vehicle, which enables the company to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities to support global military healthcare programs. The Pharmaceutical Prime Vendor Global Program is designed to provide flexible and scalable medical supply support across multiple therapeutic domains, with potential for additional regional awards to multiple contractors. This delivery order reflects the company's established capability to meet federal procurement requirements through competitive processes and its ongoing role in sustaining military medical readiness.
Quick answers
Who was awarded contract SPE2DB25FJZ71?
SPE2DB25FJZ71 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FJZ71 worth?
The government has obligated $17,702 on SPE2DB25FJZ71.
Is contract SPE2DB25FJZ71 an order under another contract?
Yes. SPE2DB25FJZ71 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJZ71 competed?
The extent of competition for SPE2DB25FJZ71 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award